Breaking News Instant updates and real-time market news.

CUBI

Customers Bancorp

$21.27 /

-0.71 (-3.23%)

18:33
01/27/21
01/27
18:33
01/27/21
18:33

Customers Bancorp sees FY21 core EPS 'at least' $4.00, consensus $4.11

"Looking ahead, we are very optimistic about the prospects of our company. The ongoing digital transformation of Customers Bancorp has positioned us well to be a major participant in the second round of PPP and to incubate new lines of businesses that leverage our fintech relationships. We expect our tangible common equity and regulatory capital levels to achieve targeted levels within the next 18 months and our credit quality to remain in line with or better than peers. The financial benefits of PPP aside, we project our recurring earnings power to expand well above the $4.00 level during 2021 and remain on track to achieve $6.00 in core EPS in 2026," concluded Mr. Sidhu.

  • 28

    Jan

CUBI Customers Bancorp
$21.27 /

-0.71 (-3.23%)

01/15/21 Wedbush
Customers Bancorp initiated with an Outperform at Wedbush
01/15/21 Wedbush
Customers Bancorp initiated with an Outperform at Wedbush
01/07/21 B. Riley Securities
Customers Bancorp price target raised to $26 from $25 at B. Riley Securities
12/04/20 B. Riley Securities
Customers Bancorp price target raised to $25 from $22 at B. Riley Securities

TODAY'S FREE FLY STORIES

Upgrade
EDP Renovaveis upgraded to Buy from Hold at Societe Generale » 05:17
03/04/21
03/04
05:17
03/04/21
05:17
EDRVF

EDP Renovaveis

$0.00 /

+ (+0.00%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EDRVF EDP Renovaveis
$0.00 /

+ (+0.00%)

02/26/21 Barclays
EDP Renovaveis price target lowered to EUR 20.30 from EUR 24.80 at Barclays
02/26/21 Exane BNP Paribas
EDP Renovaveis upgraded to Outperform from Neutral at Exane BNP Paribas
02/26/21 Exane BNP Paribas
EDP Renovaveis upgraded to Outperform from Neutral at Exane BNP Paribas
02/22/21 JPMorgan
EDP Renovaveis price target raised to EUR 22.60 from EUR 21.30 at JPMorgan
Downgrade
Idemitsu Kosan downgraded to Neutral from Outperform at SMBC Nikko » 05:15
03/04/21
03/04
05:15
03/04/21
05:15
IDKOY

Idemitsu Kosan

$0.00 /

+ (+0.00%)

SMBC Nikko analyst Koji…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IDKOY Idemitsu Kosan
$0.00 /

+ (+0.00%)

01/26/21 Jefferies
Idemitsu Kosan downgraded to Hold from Buy at Jefferies
06/09/20 Daiwa
Idemitsu Kosan downgraded to Neutral from Buy at Daiwa
Upgrade
Inpex upgraded to Outperform from Neutral at SMBC Nikko » 05:15
03/04/21
03/04
05:15
03/04/21
05:15
IPHXY

Inpex

$0.00 /

+ (+0.00%)

SMBC Nikko analyst Koji…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Downgrade
Mitsubishi Estate Co. downgraded to Neutral from Buy at Mizuho » 05:14
03/04/21
03/04
05:14
03/04/21
05:14
MITEY

Mitsubishi Estate Co.

$0.00 /

+ (+0.00%)

Mizuho analyst Yoshihiro…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MITEY Mitsubishi Estate Co.
$0.00 /

+ (+0.00%)

10/07/20 Goldman Sachs
Mitsubishi Estate Co. upgraded to Buy from Neutral at Goldman Sachs
05/06/20 Goldman Sachs
Mitsubishi Estate Co. downgraded to Neutral from Buy at Goldman Sachs
04/06/20 Jefferies
Mitsubishi Estate Co. initiated with a Buy at Jefferies
Hot Stocks
Galapagos announces interim results from MANTA, MANTA-RAy studies » 05:13
03/04/21
03/04
05:13
03/04/21
05:13
GLPG

Galapagos

$82.20 /

-2.63 (-3.10%)

, GILD

Gilead

$62.76 /

-0.245 (-0.39%)

Galapagos (GLPG)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GLPG Galapagos
$82.20 /

-2.63 (-3.10%)

GILD Gilead
$62.76 /

-0.245 (-0.39%)

GLPG Galapagos
$82.20 /

-2.63 (-3.10%)

03/02/21 Barclays
Galapagos price target lowered to EUR 69 from EUR 85.50 at Barclays
02/23/21 BofA
Galapagos upgraded to Neutral from Underperform at BofA
02/23/21 BofA
Galapagos upgraded to Neutral from Underperform at BofA
02/19/21 Raymond James
Raymond James upgrades 'heavily discounted' Galapagos to Outperform
GILD Gilead
$62.76 /

-0.245 (-0.39%)

02/12/21 Morgan Stanley
Amgen court decision may have readthrough for Gilead, says Morgan Stanley
02/11/21 Maxim
Galapagos downgraded to Hold at Maxim after discontinued Phase 3 ISABELA trials
02/10/21 Maxim
Maxim downgrades Galapagos after idiopathic pulmonary fibrosis failure
01/29/21 Jefferies
Carvana, Walmart among 13 additions to Jefferies Franchise Picks list
GLPG Galapagos
$82.20 /

-2.63 (-3.10%)

GILD Gilead
$62.76 /

-0.245 (-0.39%)

GILD Gilead
$62.76 /

-0.245 (-0.39%)

GLPG Galapagos
$82.20 /

-2.63 (-3.10%)

GILD Gilead
$62.76 /

-0.245 (-0.39%)

GILD Gilead
$62.76 /

-0.245 (-0.39%)

Upgrade
Kuehne & Nagel upgraded to Add from Sell at AlphaValue » 05:12
03/04/21
03/04
05:12
03/04/21
05:12
KHNGY

Kuehne & Nagel

$0.00 /

+ (+0.00%)

AlphaValue analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KHNGY Kuehne & Nagel
$0.00 /

+ (+0.00%)

02/23/21 Bernstein
Kuehne & Nagel upgraded to Outperform from Market Perform at Bernstein
01/12/21 UBS
Kuehne & Nagel price target raised to CHF 201 from CHF 173 at UBS
10/22/20 Berenberg
Kuehne & Nagel price target raised to CHF 165 from CHF 150 at Berenberg
10/22/20 Bernstein
Kuehne & Nagel downgraded to Market Perform from Outperform at Bernstein
Upgrade
RWE AG upgraded to Buy from Hold at Societe Generale » 05:11
03/04/21
03/04
05:11
03/04/21
05:11
RWEOY

RWE AG

$0.00 /

+ (+0.00%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RWEOY RWE AG
$0.00 /

+ (+0.00%)

02/19/21 Barclays
RWE AG price target lowered to EUR 41 from EUR 42 at Barclays
01/12/21 Barclays
RWE AG price target raised to EUR 42 from EUR 40 at Barclays
01/07/21 JPMorgan
RWE AG price target lowered to EUR 37.50 from EUR 38 at JPMorgan
12/08/20 Kepler Cheuvreux
RWE AG upgraded to Hold from Reduce at Kepler Cheuvreux
Upgrade
Societe Generale double upgrades Reckitt Benckiser to Buy from Sell » 05:10
03/04/21
03/04
05:10
03/04/21
05:10
RBGLY

Reckitt Benckiser

$0.00 /

+ (+0.00%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RBGLY Reckitt Benckiser
$0.00 /

+ (+0.00%)

RBGLY Reckitt Benckiser
$0.00 /

+ (+0.00%)

05:07 Today Societe Generale
Reckitt Benckiser upgraded to Buy from Sell at Societe Generale
02/25/21 Barclays
Reckitt Benckiser price target lowered to 9,100 GBp from 9,600 GBp at Barclays
02/25/21 RBC Capital
Reckitt Benckiser price target raised to 6,800 GBp at RBC Capital
02/25/21 Berenberg
Reckitt Benckiser price target lowered to 8,385 GBp from 9,100 GBp at Berenberg
Upgrade
Rentokil upgraded to Add from Hold at Peel Hunt » 05:07
03/04/21
03/04
05:07
03/04/21
05:07
RTOKY

Rentokil

$0.00 /

+ (+0.00%)

Peel Hunt analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RTOKY Rentokil
$0.00 /

+ (+0.00%)

02/02/21 Berenberg
Rentokil initiated with a Sell at Berenberg
01/14/21 JPMorgan
Rentokil price target raised to 595 GBp from 585 GBp at JPMorgan
01/12/21 Morgan Stanley
Rentokil price target raised to 630 GBp from 620 GBp at Morgan Stanley
01/11/21 RBC Capital
Rentokil price target raised to 625 GBp from 600 GBp at RBC Capital
Upgrade
Reckitt Benckiser upgraded to Buy from Sell at Societe Generale » 05:07
03/04/21
03/04
05:07
03/04/21
05:07
RBGLY

Reckitt Benckiser

$0.00 /

+ (+0.00%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RBGLY Reckitt Benckiser
$0.00 /

+ (+0.00%)

RBGLY Reckitt Benckiser
$0.00 /

+ (+0.00%)

02/25/21 Barclays
Reckitt Benckiser price target lowered to 9,100 GBp from 9,600 GBp at Barclays
02/25/21 RBC Capital
Reckitt Benckiser price target raised to 6,800 GBp at RBC Capital
02/25/21 Berenberg
Reckitt Benckiser price target lowered to 8,385 GBp from 9,100 GBp at Berenberg
02/25/21 Jefferies
Reckitt Benckiser upgraded to Hold from Underperform at Jefferies
Earnings
Baozun reports Q4 EPS 57c, consensus 56c » 05:06
03/04/21
03/04
05:06
03/04/21
05:06
BZUN

Baozun

$45.90 /

-1.51 (-3.18%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BZUN Baozun
$45.90 /

-1.51 (-3.18%)

BZUN Baozun
$45.90 /

-1.51 (-3.18%)

01/26/21 Alliance Global Partners
iClick Interactive Asia price target raised to $21 from $18 at Alliance Global
01/26/21 Benchmark
iClick, Baozun partnership a strategic positive for both, says Benchmark
01/26/21 CICC
Baozun downgraded to Market Perform from Outperform at CICC
01/25/21 CLSA
Baozun upgraded to Buy from Outperform at CLSA
BZUN Baozun
$45.90 /

-1.51 (-3.18%)

BZUN Baozun
$45.90 /

-1.51 (-3.18%)

Upgrade
Whitbread upgraded to Overweight from Neutral at JPMorgan » 05:06
03/04/21
03/04
05:06
03/04/21
05:06
WTBDY

Whitbread

$0.00 /

+ (+0.00%)

JPMorgan analyst Estelle…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WTBDY Whitbread
$0.00 /

+ (+0.00%)

02/18/21 Morgan Stanley
Whitbread price target raised to 3,500 GBp from 3,000 GBp at Morgan Stanley
02/12/21 Berenberg
Whitbread price target raised to 3,600 GBp from 2,500 GBp at Berenberg
01/13/21 Peel Hunt
Whitbread downgraded to Hold from Buy at Peel Hunt
12/17/20 Societe Generale
Whitbread price target raised to 2,780 GBp from 2,030 GBp at Societe Generale
Downgrade
InterContinental downgraded to Underweight from Neutral at JPMorgan » 05:05
03/04/21
03/04
05:05
03/04/21
05:05
IHG

InterContinental

$71.29 /

+0.19 (+0.27%)

JPMorgan analyst Estelle…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IHG InterContinental
$71.29 /

+0.19 (+0.27%)

IHG InterContinental
$71.29 /

+0.19 (+0.27%)

03/03/21 JPMorgan
InterContinental downgraded to Underweight from Neutral at JPMorgan
02/24/21 Deutsche Bank
InterContinental price target lowered to 5,380 GBp at Deutsche Bank
02/24/21 Deutsche Bank
InterContinental downgraded to Hold from Buy at Deutsche Bank
02/22/21 Peel Hunt
InterContinental downgraded to Reduce from Hold at Peel Hunt
Upgrade
Passage Bio upgraded to Buy from Neutral at Goldman Sachs » 04:58
03/04/21
03/04
04:58
03/04/21
04:58
PASG

Passage Bio

$20.12 /

+0.48 (+2.44%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$20.12 /

+0.48 (+2.44%)

PASG Passage Bio
$20.12 /

+0.48 (+2.44%)

02/04/21
Fly Intel: Top five analyst initiations
02/04/21 Guggenheim
Passage Bio initiated with a Buy at Guggenheim
01/25/21 Citi
Citi upgrades Passage Bio to Buy after pullback and ahead of data
01/25/21 Citi
Passage Bio upgraded to Buy from Neutral at Citi
PASG Passage Bio
$20.12 /

+0.48 (+2.44%)

  • 22
    Jan
PASG Passage Bio
$20.12 /

+0.48 (+2.44%)

PASG Passage Bio
$20.12 /

+0.48 (+2.44%)

Downgrade
LiveRamp downgraded to Market Perform from Outperform at BMO Capital » 04:56
03/04/21
03/04
04:56
03/04/21
04:56
RAMP

LiveRamp

$59.24 /

-5.335 (-8.26%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RAMP LiveRamp
$59.24 /

-5.335 (-8.26%)

RAMP LiveRamp
$59.24 /

-5.335 (-8.26%)

02/09/21 Craig-Hallum
LiveRamp price target raised to $100 from $80 at Craig-Hallum
02/09/21 Susquehanna
LiveRamp price target raised to $90 from $85 at Susquehanna
02/09/21 Morgan Stanley
LiveRamp price target raised to $93 from $85 at Morgan Stanley
01/28/21 Wells Fargo
LiveRamp price target raised to $95 from $87 at Wells Fargo
RAMP LiveRamp
$59.24 /

-5.335 (-8.26%)

  • 10
    Feb
RAMP LiveRamp
$59.24 /

-5.335 (-8.26%)

RAMP LiveRamp
$59.24 /

-5.335 (-8.26%)

Conference/Events
Credit Suisse to hold a virtual conference » 04:55
03/04/21
03/04
04:55
03/04/21
04:55
ABC

AmerisourceBergen

$103.35 /

-0.82 (-0.79%)

, AFMD

Affimed N.V.

$5.60 /

-0.07 (-1.23%)

, AMED

Amedisys

$241.61 /

-11.92 (-4.70%)

, AZN

AstraZeneca

$47.17 /

-0.55 (-1.15%)

, BNTX

BioNTech

$97.43 /

-7.43 (-7.09%)

, CSL

Carlisle

$147.55 /

-2.92 (-1.94%)

, CVAC

CureVac

$83.44 /

-9.76 (-10.47%)

, FMS

Fresenius Medical

$34.71 /

-0.615 (-1.74%)

, GLPG

Galapagos

$82.20 /

-2.63 (-3.10%)

, GLTO

Galecto

$9.90 /

-0.45 (-4.35%)

, GSK

GlaxoSmithKline

$34.24 /

+0.15 (+0.44%)

, IVA

Inventiva

$15.00 /

-1.9 (-11.24%)

, IPSEY

Ipsen

$0.00 /

+ (+0.00%)

, LNTH

Lantheus

$18.45 /

+0.08 (+0.44%)

, NOV

NOV Inc.

$15.03 /

+0.04 (+0.27%)

, NOVO

Novo Group Inc

$0.00 /

+ (+0.00%)

, NVS

Novartis

$87.54 /

-0.635 (-0.72%)

, PHG

Philips

$54.00 /

-1.23 (-2.23%)

, SNY

Sanofi

$45.46 /

-0.495 (-1.08%)

, TAK

Takeda Pharmaceutical

$17.70 /

+0.45 (+2.61%)

, ZEAL

Zealand Pharma

$31.52 /

-1.44 (-4.37%)

2021 London Global…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
ABC AmerisourceBergen
$103.35 /

-0.82 (-0.79%)

AFMD Affimed N.V.
$5.60 /

-0.07 (-1.23%)

AMED Amedisys
$241.61 /

-11.92 (-4.70%)

AZN AstraZeneca
$47.17 /

-0.55 (-1.15%)

BNTX BioNTech
$97.43 /

-7.43 (-7.09%)

CSL Carlisle
$147.55 /

-2.92 (-1.94%)

CVAC CureVac
$83.44 /

-9.76 (-10.47%)

FMS Fresenius Medical
$34.71 /

-0.615 (-1.74%)

GLPG Galapagos
$82.20 /

-2.63 (-3.10%)

GLTO Galecto
$9.90 /

-0.45 (-4.35%)

GSK GlaxoSmithKline
$34.24 /

+0.15 (+0.44%)

IVA Inventiva
$15.00 /

-1.9 (-11.24%)

IPSEY Ipsen
$0.00 /

+ (+0.00%)

LNTH Lantheus
$18.45 /

+0.08 (+0.44%)

NOV NOV Inc.
$15.03 /

+0.04 (+0.27%)

NVS Novartis
$87.54 /

-0.635 (-0.72%)

PHG Philips
$54.00 /

-1.23 (-2.23%)

SNY Sanofi
$45.46 /

-0.495 (-1.08%)

TAK Takeda Pharmaceutical
$17.70 /

+0.45 (+2.61%)

ZEAL Zealand Pharma
$31.52 /

-1.44 (-4.37%)

ABC AmerisourceBergen
$103.35 /

-0.82 (-0.79%)

02/09/21 Mizuho
AmerisourceBergen price target raised to $114 from $104 at Mizuho
02/08/21 Cowen
AmerisourceBergen price target raised to $150 from $145 at Cowen
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform after Q1 report at Evercore ISI
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform from In Line at Evercore ISI
AFMD Affimed N.V.
$5.60 /

-0.07 (-1.23%)

AMED Amedisys
$241.61 /

-11.92 (-4.70%)

02/23/21 Benchmark
Amedisys price target raised to $325 from $275 at Benchmark
02/08/21 Deutsche Bank
Amedisys price target raised to $340 from $275 at Deutsche Bank
01/05/21 Truist
Amedisys price target raised to $325 from $280 at Truist
11/03/20 Barclays
Amedisys price target raised to $298 from $290 at Barclays
AZN AstraZeneca
$47.17 /

-0.55 (-1.15%)

02/25/21
Fly Intel: Top five analyst upgrades
02/25/21 UBS
AstraZeneca upgraded to Buy from Neutral at UBS
02/04/21 Piper Sandler
Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
BNTX BioNTech
$97.43 /

-7.43 (-7.09%)

02/23/21 B. Riley Securities
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
CSL Carlisle
$147.55 /

-2.92 (-1.94%)

01/26/21 Longbow
Carlisle price target raised to $160 from $150 at Longbow
01/08/21 Oppenheimer
Carlisle price target raised to $175 from $160 at Oppenheimer
11/13/20
Carlisle cut to Hold at Loop Capital on valuation
11/13/20 Loop Capital
Carlisle downgraded to Hold from Buy at Loop Capital
CVAC CureVac
$83.44 /

-9.76 (-10.47%)

01/07/21 Morgan Stanley
CureVac COVID-19 deal provides 'sentiment boost' for Bayer, says Morgan Stanley
12/10/20 Credit Suisse
CureVac downgraded to Underperform on rising valuation at Credit Suisse
12/10/20 Credit Suisse
CureVac downgraded to Underperform from Neutral at Credit Suisse
11/02/20 Piper Sandler
CureVac's positive vaccine data bodes well for Arcturus's ARCT-021, says Piper
FMS Fresenius Medical
$34.71 /

-0.615 (-1.74%)

03/02/21 Berenberg
Fresenius Medical price target lowered to EUR 79.50 from EUR 80.40 at Berenberg
02/26/21 JPMorgan
Fresenius Medical price target raised to EUR 52.40 from EUR 51.10 at JPMorgan
02/24/21 Truist
Fresenius Medical cut to Hold at Truist on more difficult operating backdrop
02/24/21 Truist
Fresenius Medical downgraded to Hold from Buy at Truist
GLPG Galapagos
$82.20 /

-2.63 (-3.10%)

03/02/21 Barclays
Galapagos price target lowered to EUR 69 from EUR 85.50 at Barclays
02/23/21 BofA
Galapagos upgraded to Neutral from Underperform at BofA
02/23/21 BofA
Galapagos upgraded to Neutral from Underperform at BofA
02/19/21 Raymond James
Raymond James upgrades 'heavily discounted' Galapagos to Outperform
GLTO Galecto
$9.90 /

-0.45 (-4.35%)

11/23/20 SVB Leerink
SVB Leerink bullish on Galecto, initiates with an Outperform
11/23/20 SVB Leerink
Galecto initiated with an Outperform at SVB Leerink
11/23/20 Credit Suisse
Galecto initiated with an Outperform at Credit Suisse
11/23/20 BofA
Galecto initiated with a Buy at BofA
GSK GlaxoSmithKline
$34.24 /

+0.15 (+0.44%)

03/03/21 H.C. Wainwright
Vir Biotechnology selloff a 'terrific buying opportunity,' says H.C. Wainwright
02/12/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,580 GBp at Morgan Stanley
02/11/21 Berenberg
GlaxoSmithKline price target lowered to 1,570 GBp from 1,720 GBp at Berenberg
02/09/21 JPMorgan
GlaxoSmithKline price target lowered to 1,300 GBp from 1,500 GBp at JPMorgan
IVA Inventiva
$15.00 /

-1.9 (-11.24%)

10/13/20 Roth Capital
Roth backs Buy on Inventiva after Lanifibranor given breakthrough designation
08/17/20 H.C. Wainwright
Inventiva price target raised to $38 from EUR 12 at H.C. Wainwright
08/05/20
Fly Intel: Top five analyst initiations
08/05/20 Roth Capital
Inventiva initiated with a Buy at Roth Capital
IPSEY Ipsen
$0.00 /

+ (+0.00%)

02/16/21 Barclays
Ipsen price target lowered to EUR 89 from EUR 96 at Barclays
01/14/21 Societe Generale
Ipsen upgraded to Buy from Hold at Societe Generale
12/08/20 Morgan Stanley
Ipsen downgraded to Equal Weight from Overweight at Morgan Stanley
12/04/20 BofA
Ipsen downgraded to Neutral from Buy at BofA
LNTH Lantheus
$18.45 /

+0.08 (+0.44%)

02/01/21
Fly Intel: Top five analyst initiations
02/01/21 SVB Leerink
SVB Leerink bullish on Lantheus, initiates with an Outperform
02/01/21 SVB Leerink
Lantheus initiated with an Outperform at SVB Leerink
12/29/20 Credit Suisse
Lantheus price target lowered to $14 from $16 at Credit Suisse
NOV NOV Inc.
$15.03 /

+0.04 (+0.27%)

01/21/21 Susquehanna
NOV Inc. price target lowered to $17 from $18 at Susquehanna
01/21/21 Wells Fargo
NOV Inc. upgraded to Overweight from Equal Weight at Wells Fargo
01/21/21 Wells Fargo
NOV Inc. upgraded to Overweight from Equal Weight at Wells Fargo
01/12/21 Citi
NOV Inc. upgraded to Buy from Neutral at Citi
NOVO Novo Group Inc
$0.00 /

+ (+0.00%)

NVS Novartis
$87.54 /

-0.635 (-0.72%)

03/01/21 Oppenheimer
Homology Medicines loses potential source of upside, says Oppenheimer
02/02/21 Morgan Stanley
Novartis price target lowered to CHF 102 from CHF 104 at Morgan Stanley
02/01/21 Truist
iRhythm price target lowered to $220 from $265 at Truist
02/01/21 Cowen
Novartis downgraded to Market Perform after 'tepid' guidance at Cowen
PHG Philips
$54.00 /

-1.23 (-2.23%)

01/26/21 Credit Suisse
Philips price target raised to EUR 45 from EUR 41 at Credit Suisse
01/26/21 JPMorgan
Philips price target raised to EUR 44.90 from EUR 44 at JPMorgan
01/26/21 UBS
Philips price target raised to EUR 54 from EUR 51 at UBS
01/25/21 Morgan Stanley
iRhythm price target raised to $288 from $227 at Morgan Stanley
SNY Sanofi
$45.46 /

-0.495 (-1.08%)

02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
01/19/21 UBS
Sanofi price target lowered to EUR 99 from EUR 100 at UBS
TAK Takeda Pharmaceutical
$17.70 /

+0.45 (+2.61%)

03/03/21 RBC Capital
Ovid downgraded to Sector Perform at RBC Capital after rally on Takeda deal
01/29/21 Morgan Stanley
Morgan Stanley downgrades Jazz to Equal Weight ahead of competitor readout
12/29/20 Needham
Needham names Phathom Pharmaceuticals Top Pick for 2021
12/15/20 Needham
Phathom Pharmaceuticals price target raised to $55 from $45 at Needham
ZEAL Zealand Pharma
$31.52 /

-1.44 (-4.37%)

03/10/20 Morgan Stanley
Zealand Pharma EPS estimates cut at Morgan Stanley
ABC AmerisourceBergen
$103.35 /

-0.82 (-0.79%)

AMED Amedisys
$241.61 /

-11.92 (-4.70%)

AZN AstraZeneca
$47.17 /

-0.55 (-1.15%)

CSL Carlisle
$147.55 /

-2.92 (-1.94%)

GLPG Galapagos
$82.20 /

-2.63 (-3.10%)

GLTO Galecto
$9.90 /

-0.45 (-4.35%)

GSK GlaxoSmithKline
$34.24 /

+0.15 (+0.44%)

LNTH Lantheus
$18.45 /

+0.08 (+0.44%)

NOV NOV Inc.
$15.03 /

+0.04 (+0.27%)

NVS Novartis
$87.54 /

-0.635 (-0.72%)

PHG Philips
$54.00 /

-1.23 (-2.23%)

SNY Sanofi
$45.46 /

-0.495 (-1.08%)

ZEAL Zealand Pharma
$31.52 /

-1.44 (-4.37%)

  • 28
    Jan
  • 13
    Jan
  • 29
    Oct
  • 14
    Aug
  • 23
    Jul
  • 10
    Jul
ABC AmerisourceBergen
$103.35 /

-0.82 (-0.79%)

AZN AstraZeneca
$47.17 /

-0.55 (-1.15%)

BNTX BioNTech
$97.43 /

-7.43 (-7.09%)

CVAC CureVac
$83.44 /

-9.76 (-10.47%)

FMS Fresenius Medical
$34.71 /

-0.615 (-1.74%)

GSK GlaxoSmithKline
$34.24 /

+0.15 (+0.44%)

NVS Novartis
$87.54 /

-0.635 (-0.72%)

PHG Philips
$54.00 /

-1.23 (-2.23%)

SNY Sanofi
$45.46 /

-0.495 (-1.08%)

TAK Takeda Pharmaceutical
$17.70 /

+0.45 (+2.61%)

ABC AmerisourceBergen
$103.35 /

-0.82 (-0.79%)

AMED Amedisys
$241.61 /

-11.92 (-4.70%)

AZN AstraZeneca
$47.17 /

-0.55 (-1.15%)

BNTX BioNTech
$97.43 /

-7.43 (-7.09%)

CVAC CureVac
$83.44 /

-9.76 (-10.47%)

GLPG Galapagos
$82.20 /

-2.63 (-3.10%)

GLTO Galecto
$9.90 /

-0.45 (-4.35%)

GSK GlaxoSmithKline
$34.24 /

+0.15 (+0.44%)

IVA Inventiva
$15.00 /

-1.9 (-11.24%)

LNTH Lantheus
$18.45 /

+0.08 (+0.44%)

NOV NOV Inc.
$15.03 /

+0.04 (+0.27%)

NVS Novartis
$87.54 /

-0.635 (-0.72%)

PHG Philips
$54.00 /

-1.23 (-2.23%)

SNY Sanofi
$45.46 /

-0.495 (-1.08%)

TAK Takeda Pharmaceutical
$17.70 /

+0.45 (+2.61%)

ABC AmerisourceBergen
$103.35 /

-0.82 (-0.79%)

AZN AstraZeneca
$47.17 /

-0.55 (-1.15%)

BNTX BioNTech
$97.43 /

-7.43 (-7.09%)

CVAC CureVac
$83.44 /

-9.76 (-10.47%)

GSK GlaxoSmithKline
$34.24 /

+0.15 (+0.44%)

NOV NOV Inc.
$15.03 /

+0.04 (+0.27%)

TAK Takeda Pharmaceutical
$17.70 /

+0.45 (+2.61%)

Conference/Events
MKM Partners healthcare analysts host an analyst/industry conference call » 04:55
03/04/21
03/04
04:55
03/04/21
04:55

MKM Partners Healthcare…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
First Foundation participates in a conference call with Wedbush » 04:55
03/04/21
03/04
04:55
03/04/21
04:55
FFWM

First Foundation

$23.54 /

+0.19 (+0.81%)

Mid-Cap Banks Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FFWM First Foundation
$23.54 /

+0.19 (+0.81%)

01/07/21 B. Riley Securities
First Foundation price target raised to $26 from $25 at B. Riley Securities
12/16/20 B. Riley Securities
First Foundation price target raised to $25 from $23 at B. Riley Securities
12/04/20 B. Riley Securities
First Foundation price target raised to $23 from $21 at B. Riley Securities
07/22/20 B. Riley FBR
First Foundation price target raised to $21 from $19 at B. Riley FBR
FFWM First Foundation
$23.54 /

+0.19 (+0.81%)

Conference/Events
Allegro MicroSystems management to meet virtually with Mizuho » 04:55
03/04/21
03/04
04:55
03/04/21
04:55
ALGM

Allegro MicroSystems

$26.56 /

-0.39 (-1.45%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
ALGM Allegro MicroSystems
$26.56 /

-0.39 (-1.45%)

02/08/21 Mizuho
Allegro MicroSystems price target raised to $35 from $30 at Mizuho
02/08/21 Credit Suisse
Allegro MicroSystems price target raised to $36 from $27 at Credit Suisse
02/03/21 Wells Fargo
Allegro MicroSystems price target raised to $36 from $30 at Wells Fargo
01/26/21 Barclays
Allegro MicroSystems price target raised to $38 from $28 at Barclays
ALGM Allegro MicroSystems
$26.56 /

-0.39 (-1.45%)

  • 05
    Feb
  • 29
    Oct
ALGM Allegro MicroSystems
$26.56 /

-0.39 (-1.45%)

ALGM Allegro MicroSystems
$26.56 /

-0.39 (-1.45%)

Conference/Events
BigCommerce management to meet virtually with Piper Sandler » 04:55
03/04/21
03/04
04:55
03/04/21
04:55
BIGC

BigCommerce

$61.37 /

-0.55 (-0.89%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIGC BigCommerce
$61.37 /

-0.55 (-0.89%)

BIGC BigCommerce
$61.37 /

-0.55 (-0.89%)

02/24/21
Fly Intel: Top five analyst upgrades
02/24/21 KeyBanc
BigCommerce upgraded to Overweight at KeyBanc
02/24/21 KeyBanc
BigCommerce upgraded to Overweight from Sector Weight at KeyBanc
02/23/21 Needham
BigCommerce price target lowered to $85 from $132 at Needham
BIGC BigCommerce
$61.37 /

-0.55 (-0.89%)

  • 13
    Nov
  • 05
    Aug
BIGC BigCommerce
$61.37 /

-0.55 (-0.89%)

BIGC BigCommerce
$61.37 /

-0.55 (-0.89%)

Conference/Events
Belden management to meet virtually with Benchmark » 04:55
03/04/21
03/04
04:55
03/04/21
04:55
BDC

Belden

$44.93 /

-0.88 (-1.92%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BDC Belden
$44.93 /

-0.88 (-1.92%)

BDC Belden
$44.93 /

-0.88 (-1.92%)

01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
12/16/20 Truist
Belden price target raised to $50 from $41 at Truist
04/27/20 Loop Capital
Belden initiated with a Buy at Loop Capital
04/27/20 Loop Capital
Belden initiated with a Buy at Loop Capital
BDC Belden
$44.93 /

-0.88 (-1.92%)

General news
8-Week Bill Auction to be released at 11:30  04:55
03/04/21
03/04
04:55
03/04/21
04:55
 
General news
4-Week Bill Auction to be released at 11:30  04:55
03/04/21
03/04
04:55
03/04/21
04:55
 
General news
3-Month Bill Announcement to be released at 11:00  04:55
03/04/21
03/04
04:55
03/04/21
04:55
 
Conference/Events
Cano Health to hold a virtual investor and analyst day » 04:55
03/04/21
03/04
04:55
03/04/21
04:55
CANO

Cano Health

$0.00 /

+ (+0.00%)

, JWS

Jaws Acquisition Corp

$13.07 /

-1.43 (-9.86%)

Cano Health to hold a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JWS Jaws Acquisition Corp
$13.07 /

-1.43 (-9.86%)

CANO Cano Health
$0.00 /

+ (+0.00%)

11/19/20 Compass Point
Compass Point upgrades PennantPark to Buy after Cano Health 'game changer'
JWS Jaws Acquisition Corp
$13.07 /

-1.43 (-9.86%)

11/19/20 Compass Point
Compass Point upgrades PennantPark to Buy after Cano Health 'game changer'
JWS Jaws Acquisition Corp
$13.07 /

-1.43 (-9.86%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.